M. Saleh

Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial

B. Bistrian, F. Welty, A. Alfaddagh, 2017, Journal of the American Heart Association.

The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial.

B. Bistrian, F. Welty, A. Alfaddagh, 2018, Journal of clinical lipidology.

An omega-3 fatty acid plasma index ≥4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment.

B. Bistrian, F. Welty, A. Alfaddagh, 2019, Atherosclerosis.

Micro-RNA 150-5p predicts overt heart failure in patients with univentricular hearts

A. Keller, T. Raedle-Hurst, H. Abdul-Khaliq, 2019, PloS one.

MicroRNA-29b/c-3p Indicate Advanced Liver Fibrosis/Cirrhosis in Univentricular Heart Patients With and Without Fontan Palliation

A. Keller, T. Raedle-Hurst, H. Abdul-Khaliq, 2020, Frontiers in Cardiovascular Medicine.

Diastolic blood pressure predicts coronary plaque volume in patients with coronary artery disease.

F. Welty, A. Alfaddagh, Tarec K Elajami, 2018, Atherosclerosis.